- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01429974
Detection of Meconium in Amniotic Fluid in Post Term Pregnancies
May 24, 2017 updated by: Sheba Medical Center
Meconium constitutes the bowel contents of the fetus and is normally expelled only after birth.
However, it may be secreted into the amniotic fluid of 20% of all fetuses.
Meconium Stained Amniotic Fluid had been recognized from ancient times as an obstetric hazard which complicates delivery and is associated with increased newborn morbidity and mortality.
At present there is no viable diagnostic test for Meconium prior to the onset of labor and the rupture of membranes.
The system developed for the detection of Meconium, based on recognizing a characteristic fluoroscopic spectral pattern emitted by Meconium under light excitation at a specific wavelength.
The diagnostic test being developed does not require penetration into the amniotic sac and is safe, painless and simple to perform.
Study Overview
Study Type
Observational
Enrollment (Actual)
27
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ramat gan, Israel
- Sheba Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Post term pregnant females
Description
Inclusion Criteria:
- 37-42 weeks regnancy without rupture of membranes
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
volunteers
|
The detection of Meconium, is based on recognizing a characteristic fluoroscopic spectral pattern emitted by Meconium under light excitation at a specific wavelength. The diagnostic test does not require penetration into the amniotic sac and is safe, painless and simple to perform. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Determine the capability for diagnosing Meconium stained Amniotic Fluid prior to a cervical ripening procedure in women, using the Amniometer device
Time Frame: prior to breakage of water
|
prior to breakage of water
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Arie Orenstein, professor, Sheba Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2011
Primary Completion (ACTUAL)
July 7, 2015
Study Completion (ACTUAL)
July 7, 2015
Study Registration Dates
First Submitted
September 6, 2011
First Submitted That Met QC Criteria
September 6, 2011
First Posted (ESTIMATE)
September 7, 2011
Study Record Updates
Last Update Posted (ACTUAL)
May 25, 2017
Last Update Submitted That Met QC Criteria
May 24, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SHEBA-11-8479-AO-CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Meconium
-
Centre Hospitalier Universitaire, AmiensCompletedPollution; Exposure | Newborn | Microbiota | Breast Milk | Meconium | Pesticide | StoolFrance
-
Ma JuanCompletedNeonatal Meconium AspirationChina
-
Seoul National University HospitalCompletedMeconium Obstruction of PrematurityKorea, Republic of
-
Windtree TherapeuticsTerminatedMeconium AspirationUnited States
-
KK Women's and Children's HospitalSingapore General Hospital; Duke-NUS Graduate Medical School; Genome Institute... and other collaboratorsRecruitingMeconium Obstruction of PrematuritySingapore
-
Seoul National University HospitalRecruitingRespiratory Distress Syndrome in Premature Infant | Meconium Obstruction of PrematurityKorea, Republic of
-
The Hospital for Sick ChildrenUnknownMeconium Aspiration SyndromeCanada
-
Cairo UniversityCompletedAzithromycin | Postpartum Endometritis | Meconium StainedEgypt
-
Medical University of ViennaCompletedMeconium IleusAustria
-
Nadja Haiden,MDCompletedMeconium Ileus | Very Low Birth Weight Infant
Clinical Trials on amniometer model po1
-
Daniela Francescato VeigaUniversidade do Vale do SapucaiCompleted
-
Johnson & Johnson Surgical Vision, Inc.TerminatedCataractUnited States
-
National University, SingaporeUnknown
-
Medtronic CardiovascularCompleted
-
Sun Yat-sen UniversityQueen's University, Belfast; Orbis; Aravind Eye Care System; Padmashree Dr. D.... and other collaboratorsCompleted
-
University of ParmaCompletedMotor Activity | Hemiplegic Cerebral PalsyItaly
-
Johnson & Johnson Surgical Vision, Inc.Active, not recruiting
-
University of PittsburghPatient-Centered Outcomes Research InstituteCompletedHearing Loss, Age-RelatedUnited States
-
CORD, LLCTerminated
-
Osmaniye Korkut Ata UniversityCompleted